Huinno, a digital healthcare innovation company, announced on the 26th that it will participate in WHX Dubai 2026, which will be held in Dubai, United Arab Emirates, from the 9th to the 12th of next month, to showcase its AI-based electrocardiogram diagnostic technology and next-generation healthcare solutions. Huinno is a company led by CEO Gil Young-jun.
WHX is an international healthcare industry expo attended by medical device companies, healthcare professionals, and buyers from around the world. It is an event where approximately 180 countries around the world participate and share the latest medical technologies and industry trends.
Building on its technological competitiveness in AI-based electrocardiogram (ECG) diagnostics, Huinno has participated in WHX for two consecutive years, consistently highlighting its technological direction and business expansion strategy for the global market. At this exhibition, the company will unveil its Memo Patch line of wearable ECG monitoring devices and its AI diagnostic platform.
The Memo Patch is a medical device designed to precisely detect intermittent abnormal electrocardiogram signals, enabling continuous measurement for up to 14 days. The exhibition also includes the Memo Patch M model, which specializes in real-time monitoring. This product recently received 510k approval from the U.S. Food and Drug Administration, demonstrating its safety and technological prowess in the global market.
The next-generation AI diagnostic platform features rapid analysis of major arrhythmias, including atrial fibrillation, based on large-scale learning data, supporting medical professionals' interpretation. The analysis period has been shortened to two days, improving diagnostic efficiency and enhancing the usability of long-term electrocardiogram data.
As cardiovascular disease management shifts from post-treatment to early detection and continuous monitoring, Huinno is expanding its market presence with solutions that reduce the burden on patients, medical professionals, and healthcare institutions. Through its AI electrocardiogram monitoring technology, the company is contributing to improved management efficiency for patients with chronic cardiovascular disease, reduced medical costs, and reduced workload for medical professionals.
Gil Young-jun, CEO of Huinno, said that WHX Dubai 2026 will be an opportunity to concretize the company's strategy to enter the global healthcare market, and that the company will present solutions that meet the needs of overseas medical sites through AI-based long-term electrocardiogram diagnostic technology and expand global partnerships and business opportunities.
- See more related articles
You must be logged in to post a comment.